http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#Head
http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#assertion
http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#provenance
http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#pubinfo
http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#assertion
http://purl.obolibrary.org/obo/MONDO_0005260
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/MONDO_0005260
http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://go.drugbank.com/drugs/DB00313
http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#association
http://www.w3.org/2000/01/rdf-schema#label
This practice is also observed with increased off-label use of psychotropic drugs includ- ing selective serotonin reuptake inhibitors (SSRIs) [12] for repetitive behaviors, stimulant medications for attention- deficit hyperactivity disorder (ADHD)-type symptoms [25], and anti-epileptic medications such as valproate for behavioral symptoms in ASD [26].
http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#association
https://w3id.org/biolink/vocab/has_population_context
http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#cohort
http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#association
https://w3id.org/biolink/vocab/publications
https://pubmed.ncbi.nlm.nih.gov/27873285/
http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#association
https://w3id.org/biolink/vocab/relation
https://w3id.org/um/neurodkg/OffLabelIndication
http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#cohort
http://www.w3.org/2000/01/rdf-schema#label
Adults
http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#cohort
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Cohort
https://go.drugbank.com/drugs/DB00313
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#provenance
http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-7641-6446
http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#pubinfo
http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB
http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#sig
http://purl.org/nanopub/x/hasSignature
MfBVm2hugtoQT1cyoowFEmdlUvy8DvrVnO0cdak5XJiDjSAdu5bCHUBr9GKTbre5ATlVJRX7QGkzNZSE+I2tNbPsRDZvgndY+aKnGTHff++tRzibWO6GWyCsihdLJrzW0oQknRqUwBDAKlPh/Gp/sGFIYVgfg4nqnz/LixWvRKo=
http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8
http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8
http://purl.org/dc/terms/created
2021-05-31T15:21:26.174+02:00
http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-7641-6446
http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs